GLP-1 Receptor Agonists and Cardiovascular Disease
GLP-1 receptor agonists were initially developed to treat diabetes and have since evolved into medications for weight management. Recent evidence shows they are highly effective in treating cardiovascular disease, kidney disease, and heart failure with preserved ejection fraction (HFpEF).
